| pubmed-article:19235032 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0006675 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0041714 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0555952 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0018684 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
| pubmed-article:19235032 | lifeskim:mentions | umls-concept:C0041703 | lld:lifeskim |
| pubmed-article:19235032 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19235032 | pubmed:dateCreated | 2009-2-23 | lld:pubmed |
| pubmed-article:19235032 | pubmed:abstractText | In 2003, the United States Food and Drug Administration (FDA) received a health claim petition for calcium supplements and reduced risk of colorectal, breast, and prostate cancers. Health claims characterize the relationship between a substance (food or food component) and disease (e.g., cancer or cardiovascular disease) or health-related condition (e.g., hypertension) and require premarket approval for the labeling of conventional foods and dietary supplements by the FDA. This review describes how the FDA used the evidence-based review system to evaluate the scientific evidence for these proposed health claims. FDA found no credible evidence to support health claims for calcium and a reduced risk of breast and prostate cancers. The agency did find limited evidence for the relationship between calcium intake and colorectal cancer risk. | lld:pubmed |
| pubmed-article:19235032 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19235032 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19235032 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19235032 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19235032 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19235032 | pubmed:issn | 1532-7914 | lld:pubmed |
| pubmed-article:19235032 | pubmed:author | pubmed-author:TrumboPaula... | lld:pubmed |
| pubmed-article:19235032 | pubmed:author | pubmed-author:EllwoodKathle... | lld:pubmed |
| pubmed-article:19235032 | pubmed:author | pubmed-author:KavanaughClau... | lld:pubmed |
| pubmed-article:19235032 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19235032 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:19235032 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19235032 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19235032 | pubmed:pagination | 157-64 | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:meshHeading | pubmed-meshheading:19235032... | lld:pubmed |
| pubmed-article:19235032 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19235032 | pubmed:articleTitle | Qualified health claims for calcium and colorectal, breast, and prostate cancers: The U.S. Food and Drug Administration's evidence-based review. | lld:pubmed |
| pubmed-article:19235032 | pubmed:affiliation | Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA. claudine.kavanaugh@fda.hhs.gov | lld:pubmed |
| pubmed-article:19235032 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19235032 | pubmed:publicationType | Review | lld:pubmed |
